









Markets
/
Stocks
/
nasdaq-icui
/

ICU Medical Inc

ICUI

139.230USD

-0.930-0.66%

Close 11/10, 16:00（ET）Quotes delayed by 15 min

3.44BMarket Cap

LossP/E TTM



ICU Medical Inc

139.230

-0.930-0.66%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of ICU Medical Inc

Currency: USD Updated: 2025-11-10

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

ICU Medical Inc's Score

Industry at a Glance

Industry Ranking

17 / 209

Overall Ranking

71 / 4611

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 6 analysts

Buy

Current Rating

181.400

Target Price

+29.42%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

ICU Medical Inc Highlights

StrengthsRisks

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 2.38B.

Undervalued

The company’s latest PE is -92.07, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 27.90M shares, increasing 4.32% quarter-over-quarter.

Held by Wasatch Global Investors

Star Investor Wasatch Global Investors holds 2.47M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.36.

Financial Health

Currency: USD Updated: 2025-11-10

The company's current financial score is 7.06, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 536.99M, representing a year-over-year decrease of 8.85%, while its net profit experienced a year-over-year decrease of 89.70%.

Score

Industry at a Glance

Previous score

7.06

Change



Financials

6.07

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.93

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.60

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.50

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.18

Key Metrics

Free cash flow

No Data

ICU Medical Inc's Company Valuation

Currency: USD Updated: 2025-11-10

The company’s current valuation score is 8.38, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -92.07, which is -70.73% below the recent high of -26.95 and -18.87% above the recent low of -109.44.

Score

Industry at a Glance

Previous score

8.38

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 17/209

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-10

The company’s current earnings forecast score is 8.33, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for ICU Medical Inc is 180.00, with a high of 200.00 and a low of 172.00.

Score

Industry at a Glance

Previous score

8.33

Change

Support & Resistance

No Data

Analyst Rating

Based on 6 analysts

Buy

Current Rating

181.400

Target Price

+29.42%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

ICU Medical Inc

ICUI

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-10

The company’s current price momentum score is 8.89, which is higher than the Healthcare Equipment & Supplies industry's average of 7.00. Sideways: Currently, the stock price is trading between the resistance level at 154.37 and the support level at 119.21, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.08

Change

-0.19

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(1)

Buy(4)

Indicators

Value

Direction

MACD(12,26,9)

4.632

Buy

RSI(14)

72.940

Buy

STOCH(KDJ)(9,3,3)

75.057

Neutral

ATR(14)

5.843

High Vlolatility

CCI(14)

191.565

Buy

Williams %R

29.727

Buy

TRIX(12,20)

0.245

Sell

StochRSI(14)

87.458

Overbought

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

132.420

Buy

MA10

126.257

Buy

MA20

122.993

Buy

MA50

124.355

Buy

MA100

125.532

Buy

MA200

134.537

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-10

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 113.00%, representing a quarter-over-quarter increase of 7.07%. The largest institutional shareholder is The Vanguard, holding a total of 2.62M shares, representing 10.61% of shares outstanding, with 2.80% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

3.26M

-0.16%

The Vanguard Group, Inc.

Star Investors

2.65M

+0.62%

Wasatch Global Investors Inc

Star Investors

2.47M

Janus Henderson Investors

2.47M

+0.08%

Fuller & Thaler Asset Management Inc.

1.39M

+0.49%

State Street Investment Management (US)

927.80K

+3.17%

Dimensional Fund Advisors, L.P.

746.92K

+18.28%

River Road Asset Management, LLC

651.49K

+206.98%

Schroder Investment Management North America Inc.

636.32K

+2.31%

Geode Capital Management, L.L.C.

604.09K

+5.55%

Risk Assessment

Currency: USD Updated: 2025-11-10

The company’s current risk assessment score is 6.67, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 0.83. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.